Human serum albumin (HSA) is an appealing material for developing novel nanomedicines as it has a high drug loading ability, self-assembling properties, long half-life, and preferential uptake by tumor and inflamed tissues [11,125]. This evidence concerns the gene ALB and neoplasm.